Related News »
They discussed his research into mesothelin and development of clinical trials using mesothelin as a target for epithelial malignant mesothelioma, which provide both pleural and peritoneal mesothelioma patients with the potential of much-needed new treatment options.
May 25, 2012 at 16:04 | Source: DVD Creation
LOS ANGELES, May 16, 2012 /PRNewswire/ -- At the 2nd Annual Symposium for Lung-Sparing Therapies for Malignant Pleural Mesothelioma held this weekend at the Sheraton Delfina in Santa Monica, CA, international experts again re-affirmed the ...
May 16, 2012 at 16:43 | Source: Yahoo Finance
For NGR-hTNF, major progress included:   -- Continued international expansion of pivotal Phase III trial (NGR015) for the treatment of malignant pleural mesothelioma: as of 31 March 2012, 167 patients had been enrolled in 35 participating centres in ...
May 25, 2012 at 14:16 | Source: Yahoo Finance
7076 NGR-hTNF as second-line treatment in malignant pleural mesothelioma (MPM) Saturday 2 June, 1:15-5:15 PM 7085 NGR-hTNF and doxorubicin in relapsed small-cell lung cancer (SCLC) Saturday 2 June, 1:15-5:15 PM 7581 NGR-hTNF plus chemotherapy as first line ...
May 17, 2012 at 04:53 | Source: Market Wire
Mr Wright was diagnosed with pleural thickening in 2001 ... A cause of death was given as malignant mesothelioma. Before he died, Mr Wright told Corries Solicitors how he often worked in a dusty environment in different parts of the factory with no ...
May 19, 2012 at 06:59 | Source: The Press in York
in Combination with Pemetrexed and Cisplatin in Patients with Unresectable Pleural Mesothelioma MORAb-009 Results of a Multicentre Phase II Clinical Trial Abstract No: 7030 Poster Discussion A First-in-Human Phase I Study of MORAb-004 (M4), a Humanised ...
May 17, 2012 at 23:01 | Source: PressePortal.de